{"id":12298,"date":"2024-11-16T00:03:14","date_gmt":"2024-11-16T00:03:14","guid":{"rendered":"https:\/\/businesstriumphs.com\/index.php\/2024\/11\/16\/biotechs-fall-apart-with-dark-cross-neutral-signal\/"},"modified":"2024-11-16T00:03:14","modified_gmt":"2024-11-16T00:03:14","slug":"biotechs-fall-apart-with-dark-cross-neutral-signal","status":"publish","type":"post","link":"https:\/\/businesstriumphs.com\/index.php\/2024\/11\/16\/biotechs-fall-apart-with-dark-cross-neutral-signal\/","title":{"rendered":"Biotechs Fall Apart with Dark Cross Neutral Signal"},"content":{"rendered":"<div>\n<p><em>(This is an excerpt from the subscriber-only <\/em>DP Weekly Wrap<em> for Friday)<\/em><\/p>\n<p>On Friday, the Biotechnology ETF (IBB) 20-day EMA crossed down through the 50-day EMA (Dark Cross) and above the 200-day EMA, generating an IT Trend Model NEUTRAL Signal. IBB recently switched to a BUY Signal on Friday November 8, and we said at the time, \u201cIBB is approaching the top of a four-month trading range (resistance), so this BUY Signal doesn\u2019t look very juicy at this time.\u201d This emphasizes why we consider Trend Model signals to be information flags, not action commands. Always check the chart.<\/p>\n<p>Part of the reason Biotechs fell apart was the nomination of Robert F. Kennedy Jr. to the Health and Human Services department. He is known to be anti-COVID vaccines and just generally not a fan of chemicals for the body. This doesn\u2019t necessarily bode well for this industry.<\/p>\n<p>Participation has been plummeting as more and more stocks lose support at key moving averages. This drop below the 200-day EMA is perilous and, given the negative indicators, the decline isn\u2019t likely over yet. The PMO is dropping below the zero line on a Crossover SELL Signal and Stochastics are below 20, signaling extreme weakness. Support is arriving around 130.00, but it doesn\u2019t look good.<\/p>\n<p>The weekly chart shows the breakdown from the rising wedge formation, which is the normal resolution from this formation. The weekly PMO is tumbling lower. Support on the weekly chart is around 123.00. That would be a painful decline added to this already deep decline.<\/p>\n<\/p>\n<h2>Introducing the new Scan Alert System!<\/h2>\n<p>Delivered to your email box at the end of the market day. You\u2019ll get the results of our proprietary scans that Erin uses to pick her \u201cDiamonds in the Rough\u201d for the DecisionPoint Diamonds Report. Get all of the results and see which ones you like best! Only $29\/month! Or, use our free trial to try it out for two weeks using coupon code: DPTRIAL2. Click <a href=\"https:\/\/www.decisionpoint.com\/products.html\" target=\"_blank\">HERE<\/a> to subscribe NOW!<\/p>\n<p><strong>Learn more about DecisionPoint.com:<\/strong><\/p>\n<div class=\"embed-responsive embed-responsive-16by9\"><\/div>\n<h4><strong>Watch the latest episode of the <em>DecisionPointTrading Room<\/em> on DP\u2019s YouTube channel <\/strong><a href=\"https:\/\/www.youtube.com\/@decisionpointcom\/videos\" target=\"_blank\"><strong>here<\/strong><\/a><strong>!<\/strong><\/h4>\n<p><a href=\"https:\/\/decisionpoint.com\/products.html\" target=\"_blank\"><\/a><\/p>\n<h2>      Try us out for two weeks with a trial subscription!<\/h2>\n<h2>         Use coupon code: DPTRIAL2 Subscribe <a href=\"https:\/\/www.decisionpoint.com\/products.html\" target=\"_blank\">HERE<\/a>!<\/h2>\n<p><strong>Technical Analysis is a windsock, not a crystal ball. \u2013Carl Swenlin<\/strong><\/p>\n<p><strong>(c) Copyright 2024 DecisionPoint.com<\/strong><\/p>\n<p><strong><em>Disclaimer:<\/em><\/strong><em>\u00a0This blog is for educational purposes only and should not be construed as financial advice. The ideas and\u00a0strategies should never be used without first assessing your own personal and financial situation, or without consulting a\u00a0financial professional.\u00a0Any opinions expressed herein are solely\u00a0those of the author, and do not in any way represent the views or opinions of any other person or entity.<\/em><\/p>\n<p><em>DecisionPoint is not a registered investment advisor. Investment and trading decisions are solely your responsibility. DecisionPoint newsletters, blogs or website materials should NOT be interpreted as a recommendation or solicitation to buy or sell any security or to take any specific action.<\/em><\/p>\n<p><strong>Helpful DecisionPoint Links:<\/strong><\/p>\n<p><a href=\"https:\/\/stockcharts.com\/school\/doku.php?st=trend+model&amp;id=chart_school:trading_strategies:decisionpoint_trend_model\" target=\"_blank\"><strong>Trend Models<\/strong><\/a><\/p>\n<p><a href=\"http:\/\/stockcharts.com\/school\/doku.php?st=pmo&amp;id=chart_school:technical_indicators:dppmo\" target=\"_blank\"><strong>Price Momentum Oscillator (PMO)<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/stockcharts.com\/school\/doku.php?st=obv&amp;id=chart_school:technical_indicators:on_balance_volume_obv\" target=\"_blank\"><strong>On Balance Volume<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/stockcharts.com\/school\/doku.php?id=chart_school:market_indicators:dpsto\" target=\"_blank\"><strong>Swenlin Trading Oscillators (STO-B and STO-V)<\/strong><\/a><\/p>\n<p><a href=\"http:\/\/stockcharts.com\/school\/doku.php?id=chart_school:market_indicators:dpitbm\" target=\"_blank\"><strong>ITBM<\/strong><\/a><strong> and <\/strong><a href=\"http:\/\/stockcharts.com\/school\/doku.php?id=chart_school:market_indicators:dpitvm\" target=\"_blank\"><strong>ITVM<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/stockcharts.com\/school\/doku.php?st=sctr&amp;id=chart_school:technical_indicators:sctr\" target=\"_blank\"><strong>SCTR Ranking<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/stockcharts.com\/articles\/chartwatchers\/2022\/02\/bear-market-rules-refresher-352.html\" target=\"_blank\">Bear Market Rules<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>(This is an excerpt from the subscriber-only DP Weekly Wrap for Friday) On Friday, the Biotechnology ETF (IBB) 20-day EMA crossed down through the 50-day EMA (Dark Cross) and above the 200-day EMA, generating an IT Trend Model NEUTRAL Signal. IBB recently switched to a BUY Signal on Friday November 8, and we said at [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":12299,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-12298","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stock"],"_links":{"self":[{"href":"https:\/\/businesstriumphs.com\/index.php\/wp-json\/wp\/v2\/posts\/12298","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/businesstriumphs.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/businesstriumphs.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/businesstriumphs.com\/index.php\/wp-json\/wp\/v2\/comments?post=12298"}],"version-history":[{"count":0,"href":"https:\/\/businesstriumphs.com\/index.php\/wp-json\/wp\/v2\/posts\/12298\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/businesstriumphs.com\/index.php\/wp-json\/wp\/v2\/media\/12299"}],"wp:attachment":[{"href":"https:\/\/businesstriumphs.com\/index.php\/wp-json\/wp\/v2\/media?parent=12298"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/businesstriumphs.com\/index.php\/wp-json\/wp\/v2\/categories?post=12298"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/businesstriumphs.com\/index.php\/wp-json\/wp\/v2\/tags?post=12298"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}